Open Access Articles

Open Access Article
Journal Club Article
NCPD Article
Mishellene McKinney
Rose Bell
Cindy Samborski
Kristopher Attwood
Grace Dean
Katherine Eakle
Wei Yu
Stephen B. Edge
CJON 2021, 25(6), 647-654 DOI: 10.1188/21.CJON.647-654
Background: Clinical trial enrollment in the United States is lacking, particularly among older adult and ethnic and racial minority populations. Objectives: The aim of the current study was to identify patient-related barriers to clinical trial participation using a mixed-methods patient survey...
No votes yet
Tina M. Mason
Richard R. Reich
Rhonda Musgrove
Junmin Whiting
Jane Fusilero
CJON 2021, 25(5), 563-570 DOI: 10.1188/21.CJON.563-570
Background: Family support and patient outcomes are linked to nurses’ attitudes toward families’ importance in patient care. Objectives: The purpose of this study was to characterize inpatient oncology nurses’ attitudes toward families’ importance in nursing care and determine characteristics...
No votes yet
Naomi Cazeau
CJON 2021, 25(4), 431-438 DOI: 10.1188/21.CJON.431-438
Background: Treatment for cancer is trending toward oral therapies, which patients can self-manage from home. Proper adherence to oral therapy is vital to safe and optimal care in this setting. Mobile health interventions (i.e., text message reminders, mobile applications, and automated calls) are...
No votes yet
Rosemary Prieto
Betty Ferrell
Jae Y. Kim
Virginia Sun
CJON 2021, 25(3), 290-296 DOI: 10.1188/21.CJON.290-296
Background: Quality of life (QOL) for patients undergoing lung resection and their family caregivers (FCGs) is often affected by surgical treatment for lung cancer. Objectives: Patients and FCGs have a great deal of distress that affects their QOL. Introducing self-management skills soon after...
No votes yet
Amanda Pace
Blaine Brower
Dawn Conway
Dayna Leis
CJON 2021, 25(2), E1-E9 DOI: 10.1188/21.CJON.E1-E9
Background: Many patients with locally advanced or metastatic urothelial carcinoma (mUC) need additional treatment options beyond PD-1 or PD-L1 inhibitors and platinum-based chemotherapies. Enfortumab vedotin-ejfv (EV) is an antibody–drug conjugate directed at Nectin-4 that received accelerated...
Average: 5 (1 vote)
Patricia Friend
Erin Dickman
Kathleen Calzone
CJON 2021, 25(2), 205-209 DOI: 10.1188/21.CJON.205-209
Oncology nurses need to be competent in the ever-expanding application of genomics in cancer care, and understanding foundational terms is necessary. A landscape analysis of Oncology Nursing Society (ONS) materials, a literature review, and expert opinion revealed inconsistencies and varying use of...
No votes yet
Ping Lei Chui
Suetyen Wai
Lee-Lee Lai
Mee Hong See
Seng Beng Tan
CJON 2021, 25(2), 174-180 DOI: 10.1188/21.CJON.174-180
Background: Cancer can cause undesired side effects that can significantly alter patients’ perceived stress and mindfulness. The integration of nonpharmacologic, complementary health interventions, such as mindful breathing, is potentially useful in reducing stress and promoting the well-being of...
No votes yet
Megha Shah
Marie Roggenkamp
Lyndsay Ferrer
Valerie Burger
Kelly J. Brassil
CJON 2021, 25(1), 69-75 DOI: 10.1188/21.CJON.69-75
Background: The risk of psychological effects from the COVID-19 pandemic is significant and manifests as stress, anxiety, depression, sleeplessness, and, in some cases, suicide. The need for psychological support services for healthcare providers should be included in all pandemic and disaster...
No votes yet
Grace Cullen
CJON 2020, 24(6), 667-672 DOI: 10.1188/20.CJON.667-672
Background: The use of antineoplastic therapy and nonessential medications at the end of life can lead to poorer quality of life for patients, decreased satisfaction with care among caregivers, financial toxicity, increased use of the emergency department, and hospitalization. Objectives: This...
No votes yet
Anne M. Reb
Tami Borneman
Denice Economou
Marissa A. Cangin
Sunita K. Patel
Louise Sharpe
CJON 2020, 24(4), 400-408 DOI: 10.1188/20.CJON.400-408
Background: Fear of cancer recurrence or progression (FOP) is a significant concern for cancer survivors. With the advent of new targeted therapies and immunotherapy, many patients with advanced cancer are living longer while dealing with uncertainty and fears related to cancer progression...
Average: 5 (1 vote)